RespireRx Pharmaceuticals Probability of Future Pink Sheet Price Finishing Over 0.00
RespireRx Pharmaceuticals' future price is the expected price of RespireRx Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of RespireRx Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Please specify RespireRx Pharmaceuticals' target price for which you would like RespireRx Pharmaceuticals odds to be computed.
RespireRx |
RespireRx Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RespireRx Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RespireRx Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| RespireRx Pharmaceuticals is not yet fully synchronised with the market data | |
| RespireRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| RespireRx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| RespireRx Pharmaceuticals currently holds 2.42 M in liabilities. RespireRx Pharmaceuticals has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist RespireRx Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, RespireRx Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RespireRx Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RespireRx to invest in growth at high rates of return. When we think about RespireRx Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RespireRx Pharmaceuticals currently holds about 21 in cash with (956.17 K) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
RespireRx Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of RespireRx Pink Sheet often depends not only on the future outlook of the current and potential RespireRx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RespireRx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 88.3 M | |
| Cash And Short Term Investments | 1398.00 |
RespireRx Pharmaceuticals Technical Analysis
RespireRx Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. RespireRx Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of RespireRx Pharmaceuticals. In general, you should focus on analyzing RespireRx Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
RespireRx Pharmaceuticals Predictive Forecast Models
RespireRx Pharmaceuticals' time-series forecasting models is one of many RespireRx Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary RespireRx Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about RespireRx Pharmaceuticals
Checking the ongoing alerts about RespireRx Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for RespireRx Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| RespireRx Pharmaceuticals is not yet fully synchronised with the market data | |
| RespireRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
| RespireRx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| RespireRx Pharmaceuticals currently holds 2.42 M in liabilities. RespireRx Pharmaceuticals has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist RespireRx Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, RespireRx Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RespireRx Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RespireRx to invest in growth at high rates of return. When we think about RespireRx Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| RespireRx Pharmaceuticals currently holds about 21 in cash with (956.17 K) of positive cash flow from operations. | |
| Roughly 21.0% of the company outstanding shares are owned by corporate insiders |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in RespireRx Pink Sheet
If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |